Antibiotic susceptibility patterns and clones of Pseudomonas aeruginosa in Swedish ICUs

References

• Hanberger H, Diekema D, Fluit A, Jones R, Struelens M, Spencer R, et al. Surveillance of antibiotic resistance in European ICUs. J Hosp Infect. 2001; 48: 161–176
   PubMed Web of Science ®Google Scholar
• Hanberger H, Erlandsson M, Burman LG, Cars O, Gill H, Lindgren S, Nilsson LE, Olsson-Liljequist B, Walther S. High antibiotic susceptibility among bacterial pathogens in Swedish ICUs. Report from a nation-wide surveillance program using TA90 as a novel index of susceptibility. Scand J Infect Dis. 2004; 36: 24–30
   PubMed Web of Science ®Google Scholar
• Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. Jama. 1995; 274: 639–644
   PubMed Web of Science ®Google Scholar
• Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006; 34: 344–353
   PubMed Web of Science ®Google Scholar
• Babcock HM, Zack JE, Garrison T, Trovillion E, Kollef MH, Fraser VJ. Ventilator-associated pneumonia in a multihospital system: differences in microbiology by location. Infect Control Hosp Epidemiol. 2003; 24: 853–858
   PubMed Web of Science ®Google Scholar
• Szabo D, Silveira F, Fujitani S, Paterson DL. Mechanisms of resistance of bacteria causing ventilator-associated pneumonia. Clin Chest Med. 2005; 26: 75–79
   PubMedGoogle Scholar
• Bonomo RA, Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis. 43 Suppl 2006; 2: S49–56
   Google Scholar
• Hanberger H, Nilsson LE, Claesson B, Karnell A, Larsson P, Rylander M, et al. New species-related MIC breakpoints for early detection of development of resistance among gramnegative bacteria in Swedish intensive care units. J Antimicrob Chemother. 1999; 44: 611–619
   PubMedGoogle Scholar
• Carmeli Y, Troillet N, Eliopoulos GM, Samore MH. Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother. 1999; 43: 1379–1382
   PubMed Web of Science ®Google Scholar
• Pena C, Guzman A, Suarez C, Dominguez MA, Tubau F, Pujol M, et al. Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients. Antimicrob Agents Chemother. 2007; 51: 1967–1971
   PubMedGoogle Scholar
• Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000; 118: 146–155
   PubMed Web of Science ®Google Scholar
• Micek ST, Lloyd AE, Ritchie DJ, Reichley RM, Fraser VJ, Kollef MH. Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother. 2005; 49: 1306–1311
   PubMed Web of Science ®Google Scholar
• Combes A, Luyt CE, Fagon JY, Wolff M, Trouillet JL, Chastre J. Impact of piperacillin resistance on the outcome of Pseudomonas ventilator-associated pneumonia. Intensive Care Med. 2006; 32: 1970–1978
   PubMedGoogle Scholar
• Brisse S, Milatovic D, Fluit AC, Kusters K, Toelstra A, Verhoef J, Schmitz FJ. Molecular surveillance of European quinolone-resistant clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp. using automated ribotyping. J Clin Microbiol. 2000; 38: 3636–3645
   PubMed Web of Science ®Google Scholar
• Speijer H, Savelkoul PH, Bonten MJ, Stobberingh EE, Tjhie JH. Application of different genotyping methods for Pseudomonas aeruginosa in a setting of endemicity in an intensive care unit. J Clin Microbiol. 1999; 37: 3654–3661
   PubMed Web of Science ®Google Scholar
• Arruda EA, Marinho IS, Boulos M, Sinto SI, Caiaffa HH, Mendes CM, et al. Nosocomial infections caused by multiresistant Pseudomonas aeruginosa. Infect Control Hosp Epidemiol. 1999; 20: 620–623
   PubMed Web of Science ®Google Scholar
• Nociari MM, Catalano M, Torrero M, Sordelli DO. Pseudomonas aeruginosa ribotyping: stability and interpretation of ribosomal operon restriction patterns. Diagn Microbiol Infect Dis. 1996; 25: 27–33
   PubMedGoogle Scholar
• Jacoby GA, Munoz-Price LS. The new beta-lactamases. N Engl J Med. 2005; 352: 380–391
   PubMed Web of Science ®Google Scholar
• Jonas D, Spitzmuller B, Weist K, Ruden H, Daschner FD. Comparison of PCR-based methods for typing Escherichia coli. Clin Microbiol Infect. 2003; 9: 823–831
   PubMedGoogle Scholar
• D'Agata EM. Rapidly rising prevalence of nosocomial multidrug-resistant, Gram-negative bacilli: a 9-year surveillance study. Infect Control Hosp Epidemiol. 2004; 25: 842–846
   PubMedGoogle Scholar
• Obritsch MD, Fish DN, MacLaren R, Jung R. Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options. Pharmacotherapy. 2005; 25: 1353–1364
   PubMed Web of Science ®Google Scholar
• Mendes RE, Kiyota KA, Monteiro J, Castanheira M, Andrade SS, Gales AC, et al. Rapid detection and identification of metallo-beta-lactamase-encoding genes by multiplex real-time PCR assay and melt curve analysis. J Clin Microbiol. 2007; 45: 544–547
   PubMed Web of Science ®Google Scholar
• Giacca M, Menzo S, Trojan S, Monti-Bragadin C. Cluster analysis of antibiotic susceptibility patterns of clinical isolates as a tool in nosocomial infection surveillance. Eur J Epidemiol. 1987; 3: 155–163
   PubMedGoogle Scholar
• Giacca M, Monti-Bragadin C. Multivariate analysis of antibiograms for typing Pseudomonas aeruginosa. Eur J Clin Microbiol. 1987; 6: 552–558
   PubMedGoogle Scholar
• Carrico JA, Silva-Costa C, Melo-Cristino J, Pinto FR, de Lencastre H, Almeida JS, et al. Illustration of a common framework for relating multiple typing methods by application to macrolide-resistant Streptococcus pyogenes. J Clin Microbiol. 2006; 44: 2524–2532
   PubMed Web of Science ®Google Scholar
• Grundmann H, Hori S, Tanner G. Determining confidence intervals when measuring genetic diversity and the discriminatory abilities of typing methods for microorganisms. J Clin Microbiol. 2001; 39: 4190–4192
   PubMed Web of Science ®Google Scholar
• Hanberger HB, LG. Cars, O. Erlandsson, M. Gill, H. Nilsson, LE. Nordlinder, D. Walther, SM. Low antibiotic resistance rates in Saureus, Ecoli and Klebsiella but not in Enterobacter and P. aeruginosa: a prospective observational study in 14 Swedish ICUs over a five year period. Scand J Infect Dis. 2007; IN PRESS.
   Google Scholar
• Goossens H. Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group. Clin Microbiol Infect. 2003; 9: 980–983
   PubMed Web of Science ®Google Scholar
• Giske CG, Libisch B, Colinon C, Scoulica E, Pagani L, Fuzi M, et al. Establishing clonal relationships between VIM-1- like metallo-beta-lactamase-producing Pseudomonas aeruginosa strains from four European countries by multilocus sequence typing. J Clin Microbiol. 2006; 44: 4309–4315
   PubMed Web of Science ®Google Scholar
• Romling U, Kader A, Sriramulu DD, Simm R, Kronvall G. Worldwide distribution of Pseudomonas aeruginosa clone C strains in the aquatic environment and cystic fibrosis patients. Environ Microbiol. 2005; 7: 1029–1038
   PubMedGoogle Scholar
• Romling U, Wingender J, Muller H, Tummler B. A major Pseudomonas aeruginosa clone common to patients and aquatic habitats. Appl Environ Microbiol. 1994; 60: 1734–1738
   PubMed Web of Science ®Google Scholar
• Dinesh SD, Grundmann H, Pitt TL, Romling U. Europeanwide distribution of Pseudomonas aeruginosa clone C. Clin Microbiol Infect. 2003; 9: 1228–1233
   PubMedGoogle Scholar
• Scott FW, Pitt TL. Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales. J Med Microbiol Jul 2004; 53: 609–615
   PubMed Web of Science ®Google Scholar
• Curran B, Jonas D, Grundmann H, Pitt T, Dowson CG. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J Clin Microbiol. 2004; 42: 5644–5649
   PubMed Web of Science ®Google Scholar
• Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?. Clin Infect Dis. 2002; 34: 634–640
   PubMed Web of Science ®Google Scholar
• Wolter DJ, Smith-Moland E, Goering RV, Hanson ND, Lister PD. Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital. Diagn Microbiol Infect Dis. 2004; 50: 43–50
   PubMed Web of Science ®Google Scholar
• Pitt TL. Epidemiological typing of Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis. 1988; 7: 238–247
   PubMed Web of Science ®Google Scholar
• Grundmann H, Schneider C, Hartung D, Daschner FD, Pitt TL. Discriminatory power of three DNA-based typing techniques for Pseudomonas aeruginosa. J Clin Microbiol. 1995; 33: 528–534
   PubMedGoogle Scholar
• Maiden MC, Bygraves JA, Feil E, Morelli G, Russell JE, Urwin R, et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A. 1998; 95: 3140–3145
   PubMed Web of Science ®Google Scholar
• MacKenzie FM, Struelens MJ, Towner KJ, Gould IM. Report of the Consensus Conference on Antibiotic Resistance; Prevention and Control (ARPAC). Clin Microbiol Infect. 2005; 11: 938–954
   PubMedGoogle Scholar